Pfizer's quit-smoking Chantix fails study in adolescent smokers
March 23, 2018 at 08:20 AM EDT
March 23 (Reuters) - Pfizer Inc said on Friday its study to test safety and effectiveness of its anti-smoking treatment Chantix in adolescent smokers failed to meet the main goal.